Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Lippo Cikarang Tbk (LPCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Lippo Cikarang Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Lippo Cikarang Tbk trades at Rp610 (market cap 3.16T, 347.4K 24h volume). The key difference: Lippo Cikarang Tbk is far larger — about 10× Diagnos Laboratorium Utama Tbk.'s market cap, and Lippo Cikarang Tbk is more actively traded (347.4K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | LPCK | |
|---|---|---|
Market Cap | 316.25B | 3.16T |
Volume | 41.7K | 347.4K |
Lot | 417 | 3.47K |
Turnover | 9.66M | 211.93M |
Average Price | 231.65 | 610.04 |
Value | 9.66M | 211.93M |
Indicative Equilibrium Price | 230 | 610 |
Indicative Equilibrium Volume | 2.4K | 102 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Lippo Cikarang Tbk
PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Read more on LPCK →
